Vimal Mehta, BioXcel CEO
On heels of psych drug approval, BioXcel dives head first into oncology R&D with new cash infusion
Two weeks after New Haven, CT biotech BioXcel Therapeutics won FDA approval for the psychiatric drug Igalmi, the biotech is making a major new move …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
